ChengDa Pharmaceuticals Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 166.14 million compared to CNY 217.23 million a year ago. Revenue was CNY 166.59 million compared to CNY 217.23 million a year ago.

Net income was CNY 29.35 million compared to CNY 65.09 million a year ago. Basic earnings per share from continuing operations was CNY 0.1897 compared to CNY 0.439 a year ago. Diluted earnings per share from continuing operations was CNY 0.1897 compared to CNY 0.439 a year ago.